2020.Dec.14

OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities

Contents: 1.Date of institutional investor conference: Dec 21, 2020 2.Time of institutional investor conference: 14:30:00 NST 3.Location of institutional investor conference: Masterlink Securities (Address: No.97-11, Sec. 2, Dunhua S. Rd., Da’an Dist., Taipei City 106, Taiwan) 4.Outline of institutional investor conference: OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities 5.Any other matters […]

HOMEWhat’s NewAnnouncementsOBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2020.Dec.04

OBI licensed the Intellectual Property Right of Global Aesthetic Medicine to a designated company

2020.Dec.25

The active cancer immunotherapy OBI-822, Adagloxad Simolenin, has been granted by National Medical Products Administration (NMPA) to proceed Phase III human clinical study